Drug Profile
FP 0023
Alternative Names: FP0023Latest Information Update: 20 Nov 2009
Price :
$50
*
At a glance
- Originator Faust Pharmaceuticals
- Developer Domain Therapeutics
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators; Genetic transcription stimulants; Utrophin activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Muscular dystrophies
Most Recent Events
- 20 Nov 2009 FP 0023 is available for partnering (http://www.domaintherapeutics.com)
- 20 Nov 2009 No development reported - Preclinical for Muscular dystrophies in France (PO)
- 06 Jun 2007 Preclinical development is ongoing